MYC and cancer: They showed that the Iso-3 treatment significantly decreases cell proliferation (1–50 μM; 24–72 h) and stimulates growth arrest of cancer cells in G0/G1 (5–50 μM; 24 h), with an increase in p21 and p27 expression and a reduction in cyclin E1, PCNA, and c-myc levels.